Huang Tzu-Ming, Lin Tsang Long, Wu Ching Ching
Department of Comparative Pathobiology, Purdue University, West Lafayette, IN 47907-2065, USA.
Avian Dis. 2009 Mar;53(1):89-93. doi: 10.1637/8268-021608-Reg.1.
Escherichia coli, Salmonella species, and Pasteurella multocida are the major bacterial pathogens isolated from poultry. Difference in susceptibility to antibiotics by microorganisms has become a major factor in drug choice and success of treatment. Great concerns have been raised regarding emerging antimicrobial resistance among bacteria that may result in unpredictable antimicrobial susceptibility and failure of therapy. The primary objective of the present study was to determine the levels of antimicrobial susceptibility/resistance of E. coli, Salmonella species, and P. multocida isolated from diseased chickens. A total of 445 E. coli isolates, 387 Salmonella spp. isolates, and 80 P. multocida isolates from diseased chickens during the period ranging from 2001 to 2003 were obtained. Minimal inhibitory concentrations of 14 antimicrobial agents against each bacterial isolate were determined using a microbroth dilution assay described by the Clinical Laboratory Standards Institute. Resistance of E. coli isolates measured as follows: 98.20% were resistant to tilmicosin, 79.33% to tetracycline, 51.46% to spectinomycin, 44.04% to gentamicin, and 40% to ampicillin. Resistance to tetracycline was found in 72.61% of Salmonella spp. isolated, followed by resistance to spectinomycin (68.48%), ampicillin (63.57%), gentamicin (63.31%), and ticarcillin (61.76%). The resistance rate of P. multocida isolates to all antimicrobials tested was less than 5%, except for tetracycline (6.25%). In summary, E. coli and Salmonella isolates were sensitive to ceftiofur and fluoroquinolones but were resistant to other antimicrobials tested, while P. multocida isolates remained sensitive to all the antimicrobial agents tested in a 3-yr analysis.
大肠杆菌、沙门氏菌和多杀性巴氏杆菌是从家禽中分离出的主要细菌病原体。微生物对抗生素敏感性的差异已成为药物选择和治疗成功的主要因素。人们对细菌中出现的抗菌药物耐药性高度关注,这可能导致不可预测的抗菌药物敏感性和治疗失败。本研究的主要目的是确定从患病鸡中分离出的大肠杆菌、沙门氏菌和多杀性巴氏杆菌的抗菌药物敏感性/耐药性水平。在2001年至2003年期间,从患病鸡中总共获得了445株大肠杆菌分离株、387株沙门氏菌分离株和80株多杀性巴氏杆菌分离株。使用临床实验室标准协会描述的微量肉汤稀释法测定了14种抗菌药物对每种细菌分离株的最低抑菌浓度。大肠杆菌分离株的耐药情况如下:98.20%对替米考星耐药,79.33%对四环素耐药,51.46%对壮观霉素耐药,44.04%对庆大霉素耐药,40%对氨苄西林耐药。在分离出的沙门氏菌中,72.61%对四环素耐药,其次是对壮观霉素(68.48%)、氨苄西林(63.57%)、庆大霉素(63.31%)和替卡西林(61.76%)耐药。除四环素(6.25%)外,多杀性巴氏杆菌分离株对所有测试抗菌药物的耐药率均低于5%。总之,在为期3年的分析中,大肠杆菌和沙门氏菌分离株对头孢噻呋和氟喹诺酮敏感,但对其他测试抗菌药物耐药,而多杀性巴氏杆菌分离株对所有测试抗菌药物仍敏感。